Documents to download

The bill would provide new delegated powers to update or amend certain regulations governing the UK’s regulatory framework for medical devices and for human and veterinary medicines. Much of this regulatory framework has come from EU regulations and directives, which the UK has implemented through powers available under the European Communities Act 1972. These powers to update existing legislation will not be available after the end of the transition period. The Government has stated that without the changes brought in by the bill, the existing regulations could only be updated in future through primary legislation.

The bill would also make some additional changes to the regulatory framework for medical devices. These changes would include powers to establish a new system for recording data on such devices and the consolidation of enforcement provisions and new sanctions.

The bill received cross-party support in the House of Commons, with each party agreeing the bill was necessary in the circumstances. However, MPs raised concerns about matters including:

  • the scope of the delegated powers available under the bill;
  • whether it would lead to less regulatory alignment with the EU;
  • why the wording of the bill’s regulation-making powers did not prioritise consideration of patient safety;
  • tackling organ harvesting and other unethical practices; and
  • the potential large policy changes it could lead to, including “hub-and-scope” dispensing.

The Government defended its position on these issues. It said the bill’s delegated powers were limited, and those powers would be subject to sufficient scrutiny. For example, the exercise of most of the delegated powers would require prior consultation with appropriate bodies and would be subject to the draft affirmative process. The Government also said it did not intend to make any bold policy changes without full consultation.

No opposition amendments were made to the bill during its House of Commons stages. However, MPs agreed some government amendments at committee stage. A new clause proposed by the Government was added at report stage. The House of Commons agreed each of these without a vote.

Documents to download

Related posts

  • Windsor Framework (Democratic Scrutiny) Regulations 2023 and the Stormont brake

    On 29 March 2023, the House of Lords is due to debate regulations that would implement the Stormont brake in domestic law. These regulations were approved by the House of Commons on 22 March 2023. The Stormont brake is a key part of the Windsor Framework agreed between the UK and the EU. This briefing explains the background to the brake and how it would work, and includes reaction from political parties.

    Windsor Framework (Democratic Scrutiny) Regulations 2023 and the Stormont brake
  • Future of adult social care

    On 30 March 2023, the House of Lords is due to debate adult social care. The debate is expected to focus on government plans for adult social care, new duties for the Care Quality Commission to assess local authorities, and several non-government reports on how adult social care in England should be reformed. This article considers these issues and outlines social care policy announcements made by successive Conservative administrations in recent years.

    Future of adult social care
  • UK-EU relationship in financial services

    In 2022, the House of Lords European Affairs Committee examined the relationship between the UK and EU in financial services. In its report, the committee said the UK’s financial services sector remained strong and that some challenges presented by Brexit had proven to be less significant than predicted. However, it warned the government against complacency, saying that ministers must ensure their future approach delivered for the sector and the wider UK economy.

    UK-EU relationship in financial services